Month: February 2025

NASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical, a leader in AI-driven ultrasound cancer diagnosis, today announced a strategic reseller partnership to deliver a comprehensive, multi-modality AI suite for breast cancer detection. This collaboration integrates iCAD’s ProFound AI® Breast Health Suite for mammography with Koios SmartUltrasound™, providing radiologists with an AI-powered pathway from screening to diagnosis. “iCAD has long been a leader, the pioneer in AI for breast imaging. It is an honor to collaborate with a company with an unmatched track record of improving clinical outcomes for patients and a rich history of innovation,” said Chad McClennan, President & CEO of Koios Medical,...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) — Partners Value Split Corp. (the “Company”) announced today that as a result of strong investor demand for its previously announced offering, it has agreed to increase the size of the offering and sell 8,000,000 Class AA Preferred Shares, Series 15 (the “Series 15 Preferred Shares”) to a syndicate of underwriters led by Scotiabank, BMO Capital Markets, CIBC Capital Markets, RBC Capital Markets and TD Securities Inc. on a bought deal basis. The Series 15 Preferred Shares will be issued at a price of $25.00 per share, for gross proceeds of $200,000,000. The Series 15 Preferred Shares will carry a fixed coupon of 5.15% and will have a final maturity of March 31, 2031. The Series 15 Preferred Shares...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES MONTRÉAL, Feb. 26, 2025 (GLOBE NEWSWIRE) — Morocco Strategic Minerals Corporation. (TSXV: MCC) (“Morocco Strategic Minerals” or the “Corporation”) is pleased to announce the closing of a non-brokered private placement, raising total gross proceeds of $1,000,000 through the issuance of 10,000,000 units of the Corporation (“Units”) at a price of $0.10 per Unit (the “Offering”). Each Unit consists in one common share of the Corporation (a “Common Share”) and one half of one Common Share purchase warrant (a “Warrant”). Each whole Warrant entitles its holder to purchase one Common Share at an exercise price of $0.15 per Common Share for a period of 24 months. All securities issued in connection with...

VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) announces that further to its news release dated February 18, 2025 the Company confirms the effective date for the consolidation of one (1) post-consolidation share for every five (5) pre-consolidation shares. Effective at the opening on Friday, February 28, 2025, the shares of the Company will commence trading on the TSX Venture Exchange on a consolidated basis. The name and stock symbol of the Company shall remain the same. Post-Consolidation Capitalization: Unlimited common shares with no par value of which approximately 30,325,737 common shares are issued and outstanding. Transfer Agent: Endeavor Trust Corporation Trading Symbol: STUD CUSIP Number: 852919208 (new) About Stallion...

SARASOTA, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that the U.S. Patent and Trademark Office (USPTO) issued an Issue Notification for our previously filed patent application (No. 17/954,864) titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.”  The projected patent number is 12,239,614 and the issue date of such patent will be March 4, 2025. The patent reinforces protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent includes newly added claims to U.S. Patent 11,491,120, which was issued to Silo in November 2022. “Strategic IP and patent expansion...

Dovre Group Plc                Inside information                February 26, 2025, at 9 pm Dovre’s subsidiary Suvic Oy Receives Notice to Proceed and Begins Construction of a 100 MWp Solar Park in Eurajoki Suvic, a subsidiary of Dovre, has received a Notice to Proceed (NTP) and will commence work on the construction of a 100 MWp solar park in Luvia, Eurajoki, in accordance with the EPC contract announced earlier on January 8, 2025, at 5.15 pm. The client for the project is Alight, a Swedish solar power developer and independent energy producer. Additionally, the parties have signed an operation and maintenance (O&M) agreement for two years, with an option to extend for an additional three years. The solar park will cover a total area of 123 hectares and will be built in two locations: the Mikola site, spanning 73 hectares, and the...

Millicom (Tigo) declares $0.75 per share interim dividend to be paid on April 15, 2025 Luxembourg, February 26, 2025 – In line with the press release published on January 14, 2025, the Board of Directors of Millicom International Cellular S.A. (“Millicom”) approved the interim dividend of $0.75 per share to be paid on April 15, 2025 (the “Payment Date”). Other important dates and information relating to the Interim Dividend are as follows:Interim Dividend Record Date: the Interim Dividend will be paid to shareholders who are registered in the U.S. with Broadridge on April 8, 2025, at 23.59 CET; Ex-dividend Date: the last trading day on which shares acquired will be eligible to receive the Interim Dividend payment, would be April 8, 2025; Currency: the Interim Dividends will be paid in U.S. dollars; Payment Date: holders of Millcom shares...